Clesse, Christophe
Cottenet, Jonathan
Lighezzolo-Alnot, Joelle
Goueslard, Karine
Scheffler, Michele
Sagot, Paul
Quantin, Catherine
Article History
Received: 6 March 2020
Accepted: 28 July 2020
First Online: 19 November 2020
Change Date: 19 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-85717-1
Competing interests
: Author PS received funding from the following commercial companies: Merck Serono, Finox Biotech, MSD France SAS, Teva Santé SAS, Allergan France, Gedeon Richter France, Effik S.A., Karl Storz Endoscopie France, GE Medical Systems SCS, Laboratoires Genevrier, H.A.C. Pharma, and Ipsen. Author PS confirms that none of this funding was used to support the research in this study. The other authors declare that they have no competing interests.